Abstract:The central canal (CC) of the spinal cord is a neurogenic niche consisting of quiescent neural stem cells (NSCs) capable of responding to traumatic damage to the spinal cord by increasing their proliferative activity and sending migrating progeny toward the site of injury, where they contribute to the formation of the glial scar. However, CC NSCs have been demonstrated to have the capability to differentiate into all neural lineage cells , but also , in response to infusion of specific growth factors that promote neuronal induction after injury, as well as when transplanted into other neurogenic niches, such as the subgranular zone of the hippocampus. This suggests that CC NSCs may represent a recruitable endogenous source of neural lineage cells that could be harnessed to replenish damaged or lost neural tissue after traumatic spinal cord injury (SCI). NSCs isolated from the CC neurogenic niche of uninjured rats and mice have been shown to display limited proliferative capacity , with significantly greater proliferative activity achieved with NSCs isolated from SCI-lesioned rats and mice indicating an injury-specific activation of the quiescent CC NSC pool. A central question that currently remains unanswered is whether, and to what extent the CC niche can spontaneously generate viable neurons, and act as a potential source of new cells to replace lost neuronal populations , and whether SCI sequalae impact future NSC neurogenic potential. To address this question, we need to understand whether the nature of the injury plays a role in the CC neurogenic niche response. In this study, we compared the intrinsic proliferative response and neurogenic potential of NSCs harvested from the CC neurogenic niche in adult female Sprague Dawley rats by culturing said NSCs across three conditions; (i) control, i.e., uninjured tissue, (ii) after compression injury 3 days before harvesting, and (iii) after simulated burst fracture injury 3 days before harvesting . We found that lacerations of the dura mater surrounding the spinal cord during a compression injury resulted in drastically altered and persistent NSC behavior encompassing both proliferation and development compared to uninjured control and compression injury with the dura intact.

Neurogenesis as a Tool for Spinal Cord Injury

Stem Cells: Current Approach and Future Prospects in Spinal Cord Injury Repair

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury

Recent advances in endogenous neural stem/progenitor cell manipulation for spinal cord injury repair

Activating Endogenous Neurogenesis for Spinal Cord Injury Repair: Recent Advances and Future Prospects

250 Harnessing the Endogenous Stem Cell Response After Spinal Cord Injury: A Novel and Translationally Relevant Therapeutic Strategy

Direct Neuronal Differentiation of Neural Stem Cells for Spinal Cord Injury Repair

Epigenetic regulation of neural stem cell differentiation towards spinal cord regeneration

Spinal Cord Injury: Animal Models, Imaging Tools and the Treatment Strategies

Advances in Neural Stem Cell Therapy for Spinal Cord Injury: Safety, Efficacy, and Future Perspectives

Human stem cell-derived neurons and neural circuitry therapeutics: Next frontier in spinal cord injury repair

Cell Transplantation for Repair of the Spinal Cord and Prospects for Generating Region-Specific Exogenic Neuronal Cells

Combinatorial strategies for cell transplantation in traumatic spinal cord injury

survival and neurogenic potential of central canal-derived neural stem cells depend on spinal cord injury type

Multipotent Mesenchymal Stem Cell-Based Therapies for Spinal Cord Injury: Current Progress and Future Prospects

Stem Cell Therapy for Spinal Cord Injury

The roles of neural stem cells in myelin regeneration and repair therapy after spinal cord injury

Restoring Motor Neurons in Spinal Cord Injury With Induced Pluripotent Stem Cells

Novel Strategies for Spinal Cord Regeneration

A core scientific problem in the treatment of central nervous system diseases: newborn neurons